Karl Madaras-Kelly
Clinical Core Director · Healthy Idaho CTR-D Program
Credentials: · · ·
History
- Present
Healthy Idaho CTR-D Program
- Present
Idaho State University · Idaho State University College of Pharmacy
- Present
Idaho State University College of Pharmacy
University of Minnesota and St. Paul Ramsey Medical Center
Residency
- 2006
ISU
University
Research
Antimicrobial Agents and Chemotherapy · 1996 · First of 4 authors · 133 citations
A review of linezolid: the first oxazolidinone antibiotic
Review · Expert Review of Anti-infective Therapy · 2004 · Last of 3 authors · 99 citations
Infection Control and Hospital Epidemiology · 2014 · First of 6 authors · 83 citations
30 papers
22 papers
- MG
21 papers
- CG
7 papers
6 papers
5 papers · 1 as a resident
- PG
5 papers
- SR
5 papers
Grants
- 2025–2030
Healthy Idaho Clinical & Translational Research Development Program
National Institute of General Medical Sciences · P20
PI · $4.8M · Boise State University
- 2020–2025
Timely Response to In-Hospital Deterioration Through Design of Actionable Augmented Intelligence
National Institute of General Medical Sciences · R01
Contact PI · $1.2M · Idaho State University
- 2012–2016
Antibiotic Spectrum Scoring to Measure Hospital-Level Antibiotic De-Escalation
National Institute of Allergy and Infectious Diseases · R15
Contact PI · $365.1K · Idaho State University
- 2008–2011
Etiology, Epidemiology, and Clinical Outcomes of Health Care Associated Pneumonia
National Institute of Allergy and Infectious Diseases · R03
Contact PI · $124.3K · Idaho State University